Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.72 | N/A | -0.55% |
management commentary, guidance changes, and full analysis available with Pro.
| -0.55% |
Tone: Defensive
Overall, management expressed caution regarding the current economic environment. They highlighted the need for strategic adjustments to navigate challenges.
Management acknowledged the challenging market conditions.
They emphasized a focus on operational efficiency moving forward.
Agilent Technologies reported earnings that slightly missed expectations, resulting in a 1.72% decline in stock price. The lack of revenue data and guidance may have contributed to investor uncertainty. Management's cautious tone suggests they are preparing for potential challenges ahead.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
REXFORD INDL RLTY IN REIT
May 12, 2014